Impact of TP53 gene Mutation Clearance and Conditioning Intensity on Outcome in MDS or AML Patients Prior to Allogeneic Stem Cell Transplantation

被引：11
|
作者：
Chan, Onyee [1 ,2 ]
Hunter, Anthony [1 ,2 ]
Talati, Chetasi [1 ]
Sallman, David A. [1 ,3 ]
Asghari, Hannah [1 ,2 ]
Song, Jinming [4 ]
Hussaini, Mohammad [4 ]
Bejanyan, Nelli [5 ]
Elmariah, Hany [5 ]
Kuykendall, Andrew T. [1 ]
Padron, Eric [2 ]
Komrokji, Rami S. [1 ,3 ,6 ]
List, Alan F. [1 ]
Lancet, Jeffrey E. [1 ]
Sweet, Kendra L. [1 ]
Mishra, Asmita [5 ]
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Div Malignant Hematol, Tampa, FL USA
[2] Univ S Florida, Dept Med, Tampa, FL 33620 USA
[3] H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematol, Tampa, FL USA
[4] H Lee Moffitt Canc Ctr & Res Inst, Dept Pathol, Tampa, FL USA
[5] H Lee Moffitt Canc Ctr & Res Inst, Dept Blood & Marrow Transplantat & Cellular Immun, Tampa, FL USA
[6] H Lee Moffitt Canc Ctr & Res Inst, Div Malignant Hematol, Tampa, FL USA
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-131530
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
149
引用
收藏
页数：4
相关论文
共 50 条
  • [1] IMPACT OF TP53 MUTATION ON OUTCOME OF MDS PATIENTS UNDERGOING ALLOGENEIC TRASPLANT
    Diez Campelo, M.
    Caballero, J. C.
    del Rey, M.
    Janusz, K.
    Lumbreras, E.
    Abaigar, M.
    Robledo, C.
    Jerez, A.
    Valcarcel, D.
    Calderon-Cabrera, C.
    Hernandez-Rivas, J. M.
    del Canizo, M. C.
    HAEMATOLOGICA, 2014, 99 : 348 - 348
  • [2] IMPACT OF TP53 MUTATION ON OUTCOME OF MDS PATIENTS UNDERGOING ALLOGENEIC STEM CELL TRANSPLANT (HSCT). GESMD STUDY
    Diez Campelo, M.
    Caballero, J. C.
    Sanchez Barba, M.
    Del Rey, M.
    Janusz, K.
    Lumbreras, E.
    Abaigar, M.
    Robledo, C.
    Jerez, A.
    Calderon-Cabrera, C.
    Such, E.
    Cervera, J.
    Sanz, G.
    Valcarcel, D.
    Hernandez-Rivas, J. M.
    Del Canizo, C.
    LEUKEMIA RESEARCH, 2015, 39 : S102 - S103
  • [3] Survival efficacy of MDS/AML patients with TP53 abnormal received allogeneic hematopoietic stem cell transplantation
    冯丹
    China Medical Abstracts(Internal Medicine), 2023, 40 (03) : 189 - 189
  • [4] FIRST EXPERIENCE OF ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS WITH MANTLE CELL LYMPHOMA WITH A MUTATION IN THE TP53 GENE
    Koroleva, D. A.
    Gabeeva, N. G.
    Drokov, M. Yu
    Vasilyeva, V. A.
    Biderman, B., V
    Tsygankova, S., V
    Bulygina, E. S.
    Galstyan, G. M.
    Sudarikov, A. B.
    Obukhova, T. N.
    Kuzmina, L. A.
    Zvonkov, E. E.
    Parovichnikova, E. N.
    Savchenko, V. G.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2020, 65 (04): : 483 - 500
  • [5] Prognostic factors influencing survival after allogeneic transplantation for AML/MDS patients with TP53 mutations
    Ciurea, Stefan O.
    Chilkulwar, Abhishek
    Saliba, Rima M.
    Chen, Julianne
    Rondon, Gabriela
    Patel, Keyur P.
    Khogeer, Haitham
    Shah, Abdul R.
    Randolph, Brion V.
    Perez, Jorge M. Ramos
    Popat, Uday
    Hosing, Chitra M.
    Bashir, Qaiser
    Mehta, Rohtesh
    Al-Atrash, Gheath
    Im, Jin
    Khouri, Issa F.
    Kebriaei, Partow
    Champlin, Richard E.
    BLOOD, 2018, 131 (26) : 2989 - 2992
  • [6] Impact of TP53 on outcome of patients with myelofibrosis undergoing hematopoietic stem cell transplantation
    Gagelmann, Nico
    Badbaran, Anita
    Salit, Rachel B.
    Schroeder, Thomas
    Gurnari, Carmelo
    Pagliuca, Simona
    Panagiota, Victoria
    Rautenberg, Christina
    Cassinat, Bruno
    Thol, Felicitas
    Wolschke, Christine
    Robin, Marie
    Heuser, Michael
    Maciejewski, Jaroslaw P.
    Reinhardt, Hans Christian
    Scott, Bart L.
    Kroeger, Nicolaus
    BLOOD, 2023, 141 (23) : 2901 - 2911
  • [7] Impact of comorbidity on the outcome of allogeneic hematopoietic stem cell transplantation in AML/MDS patients.
    Shahjahan, M
    Alamo, J
    Delima, M
    Khouri, I
    Gajewski, J
    Andersson, BS
    Champlin, RE
    Giralt, S
    BLOOD, 2003, 102 (11) : 708A - 708A
  • [8] Survival efficacy of MDS/AML patients with tp53 gene alteration received allo-geneic hematopoietic stem cell transplantation
    Feng, D.
    Jiang, E.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 233 - 234
  • [9] TP53 Mutations in AML Predict Adverse Outcome in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant
    Getta, Bartlomiej M.
    Ghosh, Arnab
    Coombs, Catherine C.
    Devlin, Sean
    Arcila, Maria
    Mohanty, Abhinita
    Levine, Ross L.
    Tallman, Martin S.
    Jakubowski, Ann A.
    Giralt, Sergio A.
    Hanash, Alan M.
    BLOOD, 2016, 128 (22)
  • [10] Phenotype of TP53 and influence on outcome after allogeneic stem cell transplantation for myelofibrosis
    Gagelmann, N.
    Badbaran, A.
    Panagiota, V
    Thol, F.
    Heuser, M.
    Wolschke, C.
    Schroeder, T.
    Rautenberg, C.
    Reinhardt, H. C.
    Cassinat, B.
    Robin, M.
    Scott, B. L.
    Kroeger, N.
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 80 - 80
12345